Kevin Ali - Mar 31, 2022 Form 4 Insider Report for Organon & Co. (OGN)

Role
Chief Executive Officer
Signature
/s/ Tarnetta V. Jones, as Attorney-in-Fact for Kevin Ali
Stock symbol
OGN
Transactions as of
Mar 31, 2022
Transactions value $
$0
Form type
4
Date filed
4/4/2022, 06:02 PM
Previous filing
Mar 2, 2022
Next filing
May 3, 2022

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OGN Restricted Stock Units Award $0 +64.4K $0.00 64.4K Mar 31, 2022 Common Stock 64.4K Direct F1, F2
transaction OGN Stock Option (right to buy) Award $0 +198K $0.00 198K Mar 31, 2022 Common Stock 198K $34.93 Direct F3

Explanation of Responses:

Id Content
F1 The Reporting Person was granted restricted stock units ("RSUs"), which represent a contingent right to receive one share of Organon & Co. ("Organon") common stock for each RSU.
F2 These RSUs vest and are distributed as shares of Organon common stock in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025.
F3 The Reporting Person was granted stock options, which vest and become exercisable in three equal installments on March 31, 2023, March 31, 2024 and March 31, 2025.